Clinical trial
Experimental Study of the Administration of a Food Supplement Containing Hydroxycitric Acid Versus Placebo in Patients With Oxalate and Calcium Phosphate Lithiasis in Whom Extracorporeal Shock Wave Lithotripsy is Indicated.
NCT05525130 is registered in ClinicalTrials.gov with Arafarma Group, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Experimental Study of the Administration of a Food Supplement Containing Hydroxycitric Acid Versus Placebo in Patients With Oxalate and Calcium Phosphate Lithiasis in Whom Extracorporeal Shock Wave Lithotripsy is Indicated.
- Lead sponsor
- Arafarma Group, S.A.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 22, 2020
- Completion date
- October 5, 2022
- Enrollment
- 81 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.